Nuvation Bio to Present New Subgroup Analyses of Pivotal Data for IBTROZI® (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses
PR Newswire•04/08/2026•08:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.